IP Library Granted Patent US 10,316,337
Granted Patent B2
US 10,316,337 · App. 15/922,451 · Granted Jun 11, 2019

Genetically engineered bacterium for the production of isobutylene

Inventors: Michael Koepke (Skokie, IL); Rasmus Overgaard Jensen (Skokie, IL)
Assignee: LANZATECH NEW ZEALAND LIMITED
C12P7/42C12N9/0006C12N9/0008C12N9/1029C12N9/1217C12N9/16C12P5/007C12P5/026C12P7/04C12P7/18C12P7/24C12P7/28C12P7/625C12Y101/01001C12Y101/01002C12Y102/07005C12Y203/01008C12Y203/01009C12Y203/01019C12Y207/02001C12Y207/02007C12Y301/0202Y02E50/343
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,316,337
App. No.
15/922,451
Granted
Jun 11, 2019
Kind
B2
Abstract

The invention relates to a genetically engineered bacterium having an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and an enzyme that converts 3-hydroxyisovalerate to isobutylene. Typically, the bacterium is capable of producing isobutylene from a gaseous substrate containing CO, CO 2 , and/or H 2 , such as syngas or an industrial waste gas.

Claims (14)

1. A genetically engineered C1-fixing bacterium comprising:

(a) an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and

(b) an enzyme that converts 3-hydroxyisovalerate to isobutylene,

wherein at least one of the enzymes is exogenous to the bacterium.

2. The bacterium of claim 1 , wherein the enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate is thioesterase (EC 3.1.2.20), phosphate butyryltransferase (EC 2.3.1.19) and butyrate kinase (EC 2.7.2.7), or CoA-transferase (EC 2.8.3.9).

3. The bacterium of claim 1 , wherein the enzyme that converts 3-hydroxyisovalerate to isobutylene is hydroxyisovalerate phosphorylase/decarboxylase or mevalonate diphosphate decarboxylase (EC 4.1.1.33).

4. The bacterium of claim 1 , wherein the bacterium further comprises one or more enzymes selected from the group consisting of citramalate synthase (EC 2.3.1.182), 3-isopropylmalate dehydratase (EC 4.2.1.35), 3-isopropylmalate dehydrogenase (EC 1.1.1.85), acetolactate synthase (EC 2.2.1.6), ketol-acid reductoisomerase (EC 1.1.1.86), dihydroxyacid dehydratase (EC 4.2.1.9), ketoisovalerate oxidoreductase (EC 1.2.7.7), 2-methylbutanoyl-CoA dehydrogenase (EC 1.3.99.12), crotonase/3-hydroxybutyryl-CoA dehydratase (EC 4.2.1.55), crotonyl-CoA carboxylase-reductase (EC 1.3.1.86), crotonyl-CoA reductase (EC 1.3.1.44), 3-hydroxypropionyl-CoA dehydratase (EC 4.2.1.116), enoyl-CoA hydratase (4.2.1.17), thiolase (EC 2.3.1.9), thioesterase (EC 3.1.2.20), phosphate butyryltransferase (EC 2.3.1.19), butyrate kinase (EC 2.7.2.7), or CoA-transferase (EC 2.8.3.9), acetoacetate decarboxylase (EC 4.1.1.4), alpha-ketoisovalerate decarboxylase (EC 4.1.1.74), 3-hydroxyisovaleryl-CoA synthase, hydroxymethylglutaryl-CoA synthase (EC 2.3.3.10), 3-hydroxybutyryl-CoA dehydratase (EC 4.2.1.55), enoyl-CoA hydratase (EC 4.2.1.17), methylcrotonyl-CoA decarboxylase, and methylcrotonoyl-CoA carboxylase (EC 6.4.1.4).

5. The bacterium of claim 1 , wherein the bacterium is an anaerobe, an acetogen, an ethanologen, a carboxydotroph, or a methanotroph.

6. The bacterium of claim 1 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia product, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides , and Thermoanaerobacter kiuvi.

7. A method of producing isobutylene comprising culturing the bacterium of claim 1 in the presence of a substrate, whereby the bacterium produces isobutylene.

8. The method of claim 7 , wherein the substrate is a gaseous substrate comprising one or more of CO, CO 2 , CH 4 , and H 2 .

9. The method of claim 7 , wherein the substrate comprises syngas or industrial waste gas.

10. The method of claim 7 , wherein the bacterium is an anaerobe, an acetogen, an ethanologen, a carboxydotroph, or a methanotroph.

11. The method of claim 7 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia product, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides , and Thermoanaerobacter kiuvi.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE PATENT NUMBE 9,5348,20 PREVIOUSLY RECORDED AT REEL: 059911 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 4, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ INC.
Reel/Frame 061084/0646 →
CORRECTIVE ASSIGNMENT TO CORRECT THE U.S. PATENT NUMBER 8,979,228 PREVIOUSLY RECORDED AT REEL: 059911 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 3, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ, INC.
Reel/Frame 061058/0076 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2022
From: VENTURE LENDING & LEASING VII, INC.; VENTURE LENDING & LEASING VIII, INC.
To: LANZATECH NEW ZEALAND LIMITED; LANZATECH, INC.; LANZATECH FREEDOM PINES BIOREFINERY LLC; LANZATECH HONG KONG LIMITED; LANZATECH PRIVATE LIMITED; LANZATECH UK LIMITED
Reel/Frame 059910/0789 →
CHANGE OF NAME Recorded May 9, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ, INC.
Reel/Frame 059911/0400 →
SECURITY INTEREST Recorded Jun 12, 2019
From: LANZATECH NEW ZEALAND LIMITED; LANZATECH, INC.; LANZATECH FREEDOM PINES BIOREFINERY LLC; LANZATECH HONG KONG LIMITED; LANZATECH PRIVATE LIMITED; LANZATECH UK LIMITED
To: VENTURE LENDING & LEASING VII, INC.; VENTURE LENDING & LEASING VIII, INC.
Reel/Frame 049452/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2018
From: KOEPKE, MICHAEL; JENSEN, RASMUS OVERGAARD
To: LANZATECH NEW ZEALAND LIMITED
Reel/Frame 045406/0762 →
Continuity (4)
Continuation 15658668 · Jul 25, 2017
Continuation 15293191 · Oct 13, 2016
Provisional Application 62240850 · Oct 13, 2015
Related Publication 20180208952A1 · Jul 26, 2018